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CASE PRESENTATION
A 65-year-old man presented with cough and hoarse-
ness for 3 months and was admitted to our hospital. Chest 
computed tomography revealed tumor around the aortic arch. 
Fluorodeoxyglucose positron emission tomography showed 
an accumulation in the same area of maximum standardized 
uptake value of 10.8 (Figs. 1, 2). Although endobronchial 
ultrasound-guided transbronchial needle aspiration failed to 
obtain a histological diagnosis, mediastinal type lung cancer 
with aortic invasion was strongly suspected. Therefore, video-
assisted thoracoscopic surgery was conducted. Because of 
lung adhesions, both the aortic arch and left main pulmonary 
artery were difficult to identify. Therefore, to avoid aortic injury, 
biopsy sites were restricted. We obtained two puncture biopsies, 
but could not obtain a histological diagnosis. Moreover, we 
could not obtain a diagnosis by permanent specimen. However, 
polymerase chain reaction using a biopsy specimen revealed 
the presence of Mycobacterium intracellulare deoxyribonucleic 
acid. Mycobacterial culture also showed the same result. Thus, 
we started to treat the patient for nontuberculous mycobacte-
ria (NTM) with clarithromycin 800 mg, rifampicin 450 mg, and 
ethambutol 750 mg on a daily basis. As shown in Figure 3, the 
abnormal shadow was significantly improved.
Mycobacterium intracellulare is one cause of NTM. 
Polymerase chain reaction can lead to a rapid confirmation of 
the pathogen.
NTM is an atypical mycobacterial infection that can 
occur in both immunocompromised and immunocompetent 
patients. The prevalence of NTM in Japan is 5.7 people for a 
population of 100,000 people. Every year approximately 1000 
human deaths are reported, and the NTM is the disease that we 
usually see in Japan.1 As Maekawa et al.2 already reported, soil 
exposure is one of the environmental risk factors in immuno-
competent patients. As a therapeutic drug for NTM, unlike 
tuberculosis, multidrug therapy containing clarithromycin or 
azithromycin, ethambutol and rifamycin is used without using 
isoniazid. The sputum conversion rate in clarythromycin and 
azithromycin were 68 and 56%, respectively, and the effi-
cacy is more restrictive than tuberculosis.3 We experienced a 
case that was highly suspected as mediastinal type lung can-
cer4 invading the aortic arch based on computed tomography 
images but turned out to be NTM. Not only malignancy but 
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FIGURE 1.  Chest CT at first visit. A, 
Axial view, B, coronal view. Around 
the aortic arch, left common carotid 
artery and left subclavian artery, there 
was an abnormality that was highly 
suspected as cancer. CT, computed 
tomography.
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also NTM should be included as one of the candidates for dif-
ferential diagnosis of mediastinal masses.
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FIGURE 2.  FDG-PET at first visit. A, 
Axial view, B, coronal view. There was 
significant uptake (maximum stan-
dardized uptake value = 10.8) at the 
tumor site. FDG-PET, fluorodeoxyglu-
cose positron emission tomography.
FIGURE 3.  Chest CT 18 months after the treatment. The 
tumor around the aorta is significantly improved. CT, com-
puted tomography.
